• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Emotional Changes (1831); Fatigue (1849); Hair Loss (1877); Headache (1880); Hypersensitivity/Allergic reaction (1907); Menstrual Irregularities (1959); Miscarriage (1962); Pain (1994); Rash (2033); Weight Changes (2607); Heavier Menses (2666); Pregnancy (3193)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of pelvic pain ('stabbing pain'), pregnancy with contraceptive device ('pregnant') and abortion spontaneous ('miscarriage') in an adult female patient who had essure inserted for female sterilisation.The occurrence of additional non-serious events is detailed below.Other product or product use issues identified: device ineffective "device ineffective".Medical conditions: essure confirmation test: bilateral occlusion.On (b)(6) 2008, the patient had essure inserted.On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), abortion spontaneous (seriousness criterion medically significant), dysmenorrhoea ("dysmenorrhea (cramping)"), menorrhagia ("menorrhagia (heavy menstrual bleeding)"), allergy to metals ("nickel allergy"), psychological trauma ("psych injury"), fatigue ("fatigue"), headache ("headaches"), migraine ("migraine"), alopecia ("hair loss"), abdominal pain ("severe cramping") and rash ("rash"), was found to have a pregnancy with contraceptive device (seriousness criterion medically significant) and was found to have weight increased ("weight gain").The patient was treated with surgery (essure removal).Essure was removed on (b)(6) 2013.At the time of the report, the pelvic pain, pregnancy with contraceptive device, abortion spontaneous, dysmenorrhoea, menorrhagia, allergy to metals, psychological trauma, weight increased, fatigue, headache, migraine, alopecia, abdominal pain and rash outcome was unknown.Pregnancy related information: retrospective report.Last menstrual period and estimated date of delivery were not provided.The pregnancy outcome was reported as spontaneous abortion.The reporter considered abdominal pain, abortion spontaneous, allergy to metals, alopecia, dysmenorrhoea, fatigue, headache, menorrhagia, migraine, pelvic pain, pregnancy with contraceptive device, psychological trauma, rash and weight increased to be related to essure.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 28-aug-2019: plaintiff fact sheet was received and the following information was received: patient¿s date of birth added; essure was inserted on (b)(6) 2008 and removed on (b)(6) 2013; the event injury was specified as dysmenorrhea (cramping), weight gain, fatigue, headaches, migraine, hair loss, severe cramping, rash, menorrhagia (heavy menstrual bleeding), nickel allergy, psych injury, stabbing pain, pregnant, miscarried and device ineffective.The case will be deleted from bayer pv database.Nullification reason: as per follow-up information received, this case was identified as a duplicate of case (b)(4).All the information from case (b)(4) has been transferred to case (b)(4).No lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981
MDR Report Key8963783
MDR Text Key161193150
Report Number2951250-2019-05405
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Other
Type of Report Initial
Report Date 09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was Device Available for Evaluation? No
Date Manufacturer Received08/28/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-